One-year Surgical Outcomes and Costs for Medicaid Versus Non-Medicaid Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass: A Single-Center Study

Surg Laparosc Endosc Percutan Tech. 2016 Feb;26(1):38-43. doi: 10.1097/SLE.0000000000000219.

Abstract

Purpose: To compare 1-year outcomes and costs between severely obese Medicaid and non-Medicaid patients who underwent laparoscopic Roux-en-Y gastric bypass surgery.

Methods: This is a single-institution retrospective review comparing 33 Medicaid patients to 99 randomly selected non-Medicaid patients (1:3 case-control). Ninety-day and 1-year outcomes were extracted from the electronic health record. Costs were obtained from the UW information technology division. Bivariate analyses were used to compare study variables.

Results: Emergency department visits (48.2% vs. 27.4%; P=0.06) and readmissions (37.0% vs. 14.7%; P=0.01) were more common for Medicaid patients. Medicaid patients had less excess body weight loss (50.7% vs. 65.6%; P=0.001) but similar comorbidity resolution and complication rates. One-year median costs were similar between Medicaid and non-Medicaid patients ($21,160 vs. $24,215; P=0.92).

Conclusions: One-year comorbidity resolution, complications, and costs following laparoscopic Roux-en-Y gastric bypass were similar between Medicaid and non-Medicaid patients. Focusing on reducing emergency department presentations and readmissions would be a high-impact area for future quality improvement initiatives.

MeSH terms

  • Adult
  • Case-Control Studies
  • Costs and Cost Analysis
  • Emergency Service, Hospital / economics
  • Emergency Service, Hospital / statistics & numerical data
  • Female
  • Gastric Bypass / economics*
  • Humans
  • Laparoscopy / economics*
  • Length of Stay
  • Male
  • Medicaid / economics*
  • Middle Aged
  • Obesity, Morbid / economics
  • Obesity, Morbid / surgery*
  • Postoperative Complications / economics
  • Postoperative Complications / etiology
  • Reoperation / economics
  • Reoperation / statistics & numerical data
  • Retrospective Studies
  • Treatment Outcome
  • United States